News and Announcements
DomaCom Appointments a New Chief Financial Officer
- Published May 09, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
DomaCom Limited (ASX: DCL) is pleased to advise that Philip Chard ACA has been appointed as Chief Financial Officer.
KEY TAKEAWAYS:
- Philip has over 25 years of experience in the financial services industry. As a senior manager at Deloitte he provided assurance and advisory services within the funds management and investment banking sectors.
- Philip has held a broad range of financial control and reporting positions within the property, funds management and banking sectors.
Philip joined DomaCom in 2015 as Financial Controller and has established strong financial reporting and financial management processes. In February 2016, he was also appointed as Company Secretary to DomaCom Limited. Ross Laidlaw who is an Executive Director of DomaCom and has held the dual roles of COO and CFO, will relinquish the role of CFO.
DomaCom CEO, Arthur Naoumidis, said, “We are excited to announce Philip’s appointment as Chief Financial Officer. His extensive experience in building and enhancing financial systems and processes will be invaluable as DomaCom continues to expand its customer base and product offerings.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
